The FDA approved insulin icodec (Awiqli) as the first once-weekly, long-acting basal insulin for glycemic control in adults with type 2 diabetes, developer Novo Nordisk announced. Of note, the agency ...
A small device implanted just beneath the skin, roughly the size of a large postage stamp and weighing about two grams, kept ...
Advocates expect the young adult population to especially benefit from the bill, since many struggle to get high-quality ...
10d
Diabetes advocates cross their fingers as a bipartisan bill revives efforts to lower insulin costs
Two-year-old Bain Brandon has Type 1 diabetes and needs insulin to live. But even with health insurance, the price tag isn’t ...
Novo Nordisk’s icodec-abae is now approved in the US for type 2 diabetes only, after a prior rejection partly due to concerns about hypoglycemia in type 1 diabetes.
A monthly out-of-pocket cap on insulin for Medicare beneficiaries with type 2 diabetes is linked to some clinical benefits as ...
EURweb on MSN
One Injection Could Replace Daily Insulin for Type 1 Diabetes Patients, Researchers Say
*A gene therapy that may eliminate, or significantly reduce, the need for daily insulin injections is preparing to enter ...
Read more from STAT contributor Brianna Abbott on the popular vote winner. And STAT’s Amanda Erickson, who edits this very newsletter, has a dispatch on the research our editors chose as the best ...
The Express Tribune on MSN
Insulin prices double as medicine costs surge
The prices of seven essential medicines, including insulin, have been significantly increased, triggering fresh concerns among patients and healthcare providers in Khyber-Pakhtunkhwa.The most alarming ...
KP Medicine Prices Surge as Insulin Costs Skyrocket as the government has approved sharp price increases for several ...
The FDA approved a once-weekly, long-acting basal insulin for adults with type 2 diabetes as an alternative to daily basal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results